Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Connaught Mycobax indications follow ACET/ACIP guidelines for TB prevention in high-risk groups.

Executive Summary

CONNAUGHT MYCOBAX PROPOSED TB INDICATIONS FOLLOW ACET/ACIP RECOMMENDATIONS for use of the Bacillus Calmette-Guerin vaccine to treat populations at high risk of developing tuberculosis. The Advisory Committee on Elimination of Tuberculosis and the Advisory Committee on Immunization Practices joint recommendations will be published in an upcoming Center for Disease Control & Prevention Morbidity & Mortality Weekly Report.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027981

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel